Winclove Probiotics B.V.
11
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Effect of a Multispecies Probiotics on Autism Symptoms in Children
Role: collaborator
PRObiotics for KIdney Transplantation
Role: collaborator
Probiotic Intervention in PCOS
Role: collaborator
Acute and Chronic Effects of Ecologic Barrier© on Mood and Cognition
Role: collaborator
Prediction of Dietary Intervention Efficacy in Mild Ulcerative Colitis Patients Based on Fecal Microbiome Signatures
Role: collaborator
Postprandial Lipids in IBS and Nutritional Treatment
Role: collaborator
The Effect of a Multispecies Probiotic on Reducing the Incidence of Antibiotic-associated Diarrhoea in Children.
Role: collaborator
Nutrition to Relieve IBS Symptoms by Targeting the Microbiota
Role: collaborator
Nutrition to Relieve IBS Constipation
Role: collaborator
Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a Questionnaire
Role: collaborator
Probiotics in Occupational Shift Workers
Role: collaborator
All 11 trials loaded